White Papers

  1. Clinical Trials Are Better, Faster, Cheaper With Big Data 12/8/2022

    The path from study design to approval is long, winding, and expensive. Explore how researchers are using artificial intelligence and advanced analytics to speed up the process, reduce costs, and get effective treatments swiftly to those who need them while tapping into data on patients from past trials.

  2. Synthetic Control Arm In Clinical Trials 12/8/2022

    Get an overview of the SCA, an external control generated with the goal of improving the interpretation of uncontrolled trials, which can enable better product development decisions.

  3. Site Perspectives On Decentralized Clinical Trials 11/15/2022

    Discover why understanding clinical research sites’ experiences and perspectives on DCTs will help industry stakeholders  refine trial design, operational procedures, and regulatory policy to better serve patients and sites.

  4. Developing A Strategy To Optimize Study Supplies 9/1/2022

    Discover how the optimization of a clinical supply strategy can decrease wasted supplies, drive down costs, and ensure supplies reach the sites on time and in the correct quantities.

  5. Hassle-Free Imaging In Clinical Trials 6/14/2022

    In this paper, writers ask readers to consider how far the field of imaging has transpired in recent times, as well as explore the latest innovations, and contemplate what possibilities lie ahead.

  6. Modernizing Direct-To-Patient Clinical Trials 5/20/2022

    This paper provides an overview of factors underlying the rapid and ongoing modernization of clinical trials and provides a short discussion of DtP trials and demonstrates how they can solve some of the difficulties you may be facing today.

  7. Insights Into Clinical Trial Enrollment 5/18/2022

    Explore the continued impact of the pandemic on clinical trial enrollment in Phase II and III studies to help the industry navigate the dynamic landscape in 2022 across four therapeutic areas (TAs).

  8. Characterizing The Use Of External Controls For Augmenting Randomized Control Arms And Confirming Benefit 4/19/2022

    Learn several approaches to constructing an external control while considering the use of hybrid designs that supplement or augment the control group in the randomized control trials (RCT) with data from an external population.

  9. DCTs: What Are They And What Are The Direct Impacts To DMs? 1/21/2022

    In 2020, the need for alternative approaches to clinical trial execution and data capture became a reality overnight. The concept of implementing components of decentralization within a clinical trial became one of ‘here and now,’ versus a concept of the future. 

  10. Decentralized Clinical Trials: The Future Of Clinical Research Is Here 12/20/2021

    This white paper provides an introduction to DCTs and summarizes the state of the industry from the perspective of different stakeholders, including the pharmaceutical and medical device industries, regulators across the world, and patients.